NEW YORK and SALT LAKE CITY - Citeline announced an expanded partnership with Recursion (NASDAQ:RXRX) on Tuesday to integrate real-world data capabilities into the biotech company’s drug development ...

PEOPLE confirms the West Coast burger chain removed '67' from its ticket system about a month ago George Rose/Getty In-N-Out Burger has officially retired the number "67" from its ticket order system, ...

Recursion is using AI to develop new drug candidates much more efficiently than the overall industry. Tempus AI's $1.27 billion trailing revenue comes from a clinical data flywheel that no competitor ...

Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.